Researchers identify a therapeutic vulnerability in aggressive childhood cancers July 09, 2026 Researchers identify a therapeutic vulnerability in aggressive childhood cancers
The Josep Carreras Institute strengthens its international presence at EHA 2026 July 01, 2026 The Josep Carreras Institute strengthens its international presence at EHA 2026
VulnerAM project seeks new vulnerabilities in aggressive myeloid leukaemias June 25, 2026 VulnerAM project seeks new vulnerabilities in aggressive myeloid leukaemias
Innomed Awards boost seven emerging biomedical projects with healthcare transfer potential June 23, 2026 Innomed Awards boost seven emerging biomedical projects with healthcare transfer potential
A Hidden DNA Genome Protector May Explain Why Health and Aging Differ Between Men and Women June 16, 2026 A Hidden DNA Genome Protector May Explain Why Health and Aging Differ Between Men and Women
The CLEPIC 2026 International Congress brings together epigenetics specialists from around the world at the Josep Carreras Institute June 15, 2026 The CLEPIC 2026 International Congress brings together epigenetics specialists from around the world at the Josep Carreras Institute
Anna Bigas co-leads a new project on T-cell Acute Lymphoblastic Leukaemia, funded by the Deutsche José Carreras Leukämie-Stiftung June 11, 2026 Anna Bigas co-leads a new project on T-cell Acute Lymphoblastic Leukaemia, funded by the Deutsche José Carreras Leukämie-Stiftung
Dr Josep Maria Ribera recognised with EHA Clinical Excellence Award June 08, 2026 Dr Josep Maria Ribera recognised with EHA Clinical Excellence Award
For the first time, scientists discover that a subset of a common blood cancer is more deadly in women than in men — and find a new targeted treatment approach May 06, 2026 For the first time, scientists discover that a subset of a common blood cancer is more deadly in women than in men — and find a new targeted treatment approach
New Molecular Tool Transforms How Clinicians Classify and Treat a Rare Blood Cancer April 29, 2026 New Molecular Tool Transforms How Clinicians Classify and Treat a Rare Blood Cancer
Scientists Identify a “Protective Switch” in the Most Common Blood Cancer, Opening New Doors for Diagnosis and Treatment April 20, 2026 Scientists Identify a “Protective Switch” in the Most Common Blood Cancer, Opening New Doors for Diagnosis and Treatment
